Hyokof LS Junior Syrup Cherry is a pediatric formulation combining Levosalbutamol (0.5mg/5ml), Ambroxol (15mg/5ml), and Guaifenesin (50mg/5ml) designed to provide comprehensive relief from respiratory conditions characterized by bronchospasm, mucus hypersecretion, and productive cough. Levosalbutamol, a selective β2-adrenergic receptor agonist, acts as a bronchodilator, facilitating airway relaxation and improving airflow in obstructive airway diseases such as asthma and bronchitis. Ambroxol serves as a mucolytic agent, enhancing the clearance of mucus by breaking down its viscosity, thereby aiding expectoration. Guaifenesin functions as an expectorant, promoting the thinning and loosening of mucus in the airways, which assists in effective cough clearance. This combination is particularly beneficial in pediatric patients presenting with acute or chronic respiratory tract infections, bronchial asthma, and other conditions involving excessive mucus production and airway obstruction. The cherry-flavored syrup formulation ensures palatability, improving compliance in children. Hyokof LS Junior Syrup should be administered as per physician’s instructions, with dosage adjusted according to age and clinical response. Caution is advised in patients with hypersensitivity to any component, cardiac disorders, or hyperthyroidism. Overall, this combination provides a synergistic approach to managing respiratory symptoms, enhancing patient comfort and recovery.